Autobio Diagnostics Co., Ltd. (SHSE:603658) commences a share repurchases on February 21, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on February 20, 2024. As per the mandate, the company is authorized to repurchase up to CNY 500 million worth of shares. The shares will be repurchased at a price of CNY 60 per share.

The source of funds for the repurchase program will be the company?s own funds. The shares repurchased will be canceled and the company?s registered capital will be reduced, which is conducive to safeguarding the company's value and shareholders' rights and enhancing investor confidence. The program will be valid for 12 months.